9 các kết quả
This application is the National Phase of PCT/KR2006/005229 filed on Dec. 6, 2006, which claims priority under 35 U.S.C. 119(a) to Patent Application Nos. 10-2006-0054519 and 10-2006-0119620 filed in Republic of Korea on Jun. 16, 2006 and Nov. 30, 2006, respectively. All of the above applications
TECHNICAL FIELD
The present invention relates to the use of N-acetyl-D-glucosamine and pharmaceutical acceptable salts thereof in the manufacture of a medicament for inhibiting the side effect of radio-chemical therapy.
BACKGROUND ART
After accepting radio-chemical treatment, patients with neoplasm
FIELD OF THE INVENTION
The present invention relates to new dietary supplement compositions comprising 5-LOXIN, glucosamine hydrochloride and curcuminoids, and optionally bromelain, chondroitin, methylsulfonylmethane, resveratrol, white Willow (Salix alba), ginger, and quercetin.
BACKGROUND OF THE
Background of the Invention
The present invention relates to acyl derivatives of glucosamines with amino acids or synthetic peptides, endowed with antitumor chemotherapeutic activity against transplanted tumors in animals, to pharmaceutical compositions containing said derivatives, to processes for
The present invention relates to specific glucosamine disaccharides, in particular to 2-N- and/or 2'-N-acylated glucosamine disaccharides, wherein at least one of the acyl groups is branched, and to compounds comprising these disaccharides. The present invention relates further to methods for
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
BACKGROUND OF THE INVENTION
The present invention relates to N-acyl derivatives of an amino sugar with an oligopeptide, endowed with antitumor chemotherapeutic activity, and to pharmaceutical compositions containing said derivatives.
Antitumor chemotherapy has been and still is an object of
This is a national-phase application of Int'l Appln. No. PCT/JP03/17030 under 35 U.S.C. 371, filed Dec. 26, 2003; the entire content of which is hereby incorporated by reference in this application.
TECHNICAL FIELD
The present invention relates to a novel nucleic acid, the nucleic acid for testing
FIELD OF THE INVENTION
This invention relates to methods for discovering agonists and antagonists of the interaction between UDP-sugars (e.g.,UDP-glucose, UDP-galactose, UDP-glucuronic acid, and UDP-N-acetyl glucosamine) and their cellular receptor, human KIAA0001 receptor. The invention also